基于强化对称度量学习和图形卷积网络的药物疾病关联的预测
Huimin Luo1,2, Chunli Zhu1,2, Jianlin Wang1,2
1School of Computer and Information Engineering, Henan University, Kaifeng, China.
Frontiers in pharmacology
|February 22, 2024
概括
这项研究引入了RSML-GCN,一种新的计算药物重新定位方法. 它通过整合网络和特征信息,有效地识别新的药物疾病关联,改善药物发现.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物发现是昂贵和缓慢的.
- 计算药物重新定位为识别药物疾病联系提供了一个有效的替代方案.
- 现有的方法在稀疏的数据和有限的功能建模方面扎.
研究的目的:
- 开发一种先进的计算方法,用于预测新型药物与疾病的关联.
- 克服现有的药物重新定位技术的局限性.
- 提高药物疾病关联预测的准确性和全面性.
主要方法:
- 拟议的RSML-GCN方法利用图形卷积网络 (GCN) 和强化对称度量学习.
- 构建了一个异质的药物疾病网络,集成关联和特征数据.
- 采用GCN来增强关联信息和隐藏特征表示的度量学习.
主要成果:
- 在识别新型药物疾病关联方面,RSML-GCN表现出卓越的预测性能.
- 该方法有效地补充了稀有的药物疾病关联数据.
- 综合实验验证了该模型在基准数据集上的有效性.
结论:
- RSML-GCN为计算药物重新定位提供了一种强大而准确的方法.
- 综合网络和高级度量学习有效地模拟了药物-疾病关系.
- 这种方法具有显著的潜力,可以加速药物发现和确定新的治疗指示.
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Drug Abuse and Addiction: Pharmacological Phenomena
476
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476
Drug Concentration Versus Time Correlation
768
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
768
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Structure-Activity Relationships and Drug Design
720
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
720


